Back to search
FDAFDA · Food and drugs·Recall number D-1139-2023

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60

Published September 6, 2023 · Recall initiated: August 23, 2023

Summary

FDA records drug Class III recall D-1139-2023, published September 6, 2023 and initiated August 23, 2023. Recalling firm: Contract Pharmaceuticals Limited Canada; Status: Terminated; Reported quantity: 11,350 bottles; Lot: Lot # 118920, exp. January 2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: slow leakage under the cap

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Contract Pharmaceuticals Limited Canada
Distributor
Nationwide in the USA.
Lot
Lot # 118920, exp. January 2024.
Risk classification
Class III
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60 recalled?

Yes. FDA published recall D-1139-2023 on September 6, 2023. Reported hazard: Defective Container: slow leakage under the cap

What should I do if I have this product?

Voluntary: Firm initiated · Letter